Ortho Evra Transdermal Contraceptive Patch from Japan
Ortho Evra weekly patch delivers norelgestromin (progestin metabolite, from 2937) and ethinyl estradiol through skin. Replaced by Xulane generic. Matrix patch qualifies as hormone-based under HTS 3006.60.00.00.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Adhesive matrix drug release profile certification needed
• Patch size/thickness specs prevent mechanical device confusion
• Avoid bulk API import; finished patch form required